EP1646398A2 - Formulations comprising factor viia and a factor vii related polypeptide - Google Patents

Formulations comprising factor viia and a factor vii related polypeptide

Info

Publication number
EP1646398A2
EP1646398A2 EP04736742A EP04736742A EP1646398A2 EP 1646398 A2 EP1646398 A2 EP 1646398A2 EP 04736742 A EP04736742 A EP 04736742A EP 04736742 A EP04736742 A EP 04736742A EP 1646398 A2 EP1646398 A2 EP 1646398A2
Authority
EP
European Patent Office
Prior art keywords
fvii
factor vii
wild type
factor
related polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04736742A
Other languages
German (de)
English (en)
French (fr)
Inventor
Egon Persson
Carsten Borgund Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Original Assignee
Novo Nordisk Health Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care AG filed Critical Novo Nordisk Health Care AG
Publication of EP1646398A2 publication Critical patent/EP1646398A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP04736742A 2003-06-13 2004-06-14 Formulations comprising factor viia and a factor vii related polypeptide Withdrawn EP1646398A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300883 2003-06-13
US48220903P 2003-06-23 2003-06-23
PCT/DK2004/000413 WO2004110469A2 (en) 2003-06-13 2004-06-14 Formulations comprising factor viia and a factor vii related polypeptide

Publications (1)

Publication Number Publication Date
EP1646398A2 true EP1646398A2 (en) 2006-04-19

Family

ID=33553692

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04736742A Withdrawn EP1646398A2 (en) 2003-06-13 2004-06-14 Formulations comprising factor viia and a factor vii related polypeptide

Country Status (3)

Country Link
EP (1) EP1646398A2 (ja)
JP (1) JP2006527216A (ja)
WO (1) WO2004110469A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2357751C2 (ru) 2001-12-21 2009-06-10 Ново Нордиск Хелт Кэр Аг Жидкая композиция полипептидов фактора vii
EP2283856B1 (en) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabilised solid compositions of factor VIIa polypeptides
ES2574581T3 (es) * 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
ATE455861T1 (de) 2004-05-04 2010-02-15 Novo Nordisk Healthcare Ag O-verknüpfte glykoformen von faktor vii und verfahren zu deren herstellung
WO2006089966A2 (en) * 2005-02-28 2006-08-31 Novo Nordisk Health Care Ag Fxiii variants with improved properties
EP1893631B1 (en) * 2005-06-17 2013-08-14 Novo Nordisk Health Care AG Dimeric and multimeric fviia compounds
WO2008009634A2 (en) * 2006-07-17 2008-01-24 Novo Nordisk Health Care Ag Factor viia analogues with increased activity for treating thrombocytopenia
EP1952822A1 (en) * 2007-01-26 2008-08-06 Novo Nordisk A/S Factor VII polypeptides with increased affinity to platelets
TWI465247B (zh) 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
US20210069306A1 (en) 2019-08-15 2021-03-11 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
ATE532858T1 (de) * 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004110469A2 *

Also Published As

Publication number Publication date
WO2004110469A2 (en) 2004-12-23
WO2004110469A3 (en) 2005-02-03
JP2006527216A (ja) 2006-11-30

Similar Documents

Publication Publication Date Title
JP5917334B2 (ja) ヒト凝固第ｖｉｉ因子ポリペプチド
JP4537059B2 (ja) ヒト凝固第ｖｉｉ因子ポリペプチド
US8921530B2 (en) Method for the production of proteins
JP4597678B2 (ja) ヒト凝固因子ｖｉｉポリペプチド
US8674074B2 (en) Coagulation factor VII polypeptides
US20070037746A1 (en) Novel compounds
ES2490590T3 (es) Polipéptidos de factor VII de coagulación humana
JP2011167193A (ja) 凝固因子ｖｉｉポリペプチド
JP4885707B2 (ja) セリンプロテアーゼを含むｇｌａ−残基の生産方法
US20090011992A1 (en) Human Coagulation Factor VII Polypeptides
US6911323B2 (en) Human coagulation factor VII polypeptides
EP1646398A2 (en) Formulations comprising factor viia and a factor vii related polypeptide
US20060116324A1 (en) Novel formulations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060113

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20070709

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20100310